Merck (MRK) Battling to Protect Key Cancer Drug as Patent Row Heats Up
Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a ...
Merck KGaA (ETR:MRK) shareholders have earned a 8.1% CAGR over the last five years
For example, the Merck KGaA (ETR:MRK) share price is up 39% in the last five years, slightly above the market return. In comparison, the share price is down 13% in a year. So let's assess the ...
Merck & Co. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts
We recently compiled a list of the 12 Undervalued Wide Moat Stocks to Buy According to Analysts. In this article, we are ...
Moderna aims 2027 approval for Merck-partnered cancer shot
Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...
Merck & Co. (MRK): One of the Best Psychedelic Stocks to Buy in 2025
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...
Merck set for patent battle with Halozyme over injectable Keytruda: WSJ
Merck (MRK) stock trended lower as Halozyme (HALO) challenges the company over injectable Keytruda patents. Read more here.
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
Merck's (NYSE:MRK) Earnings May Just Be The Starting Point
NYSE:MRK Earnings and Revenue History March 4th 2025 How Do Unusual Items Influence Profit? To properly understand Merck's profit results, we need to consider the US$4.2b expense ...
Morningstar2d
Merck & Co Inc MRK
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...